Advertisement

Progress in the Treatment of Gout Using Western and Chinese Medicine

  • Xiang Wang
  • Yan-gang WangEmail author
Commentary
  • 17 Downloads

Abstract

Gout is a crystal-related arthropathy resulting from the deposition of monosodium urate. Identifying appropriate treatments and novel drugs to decrease serum uric acid (SUA) levels and gout risk has been a major focus. By performing extensive literature review on the pathogenesis and Chinese and Western medicine treatment of gout, this paper aimed to identify novel targets for effective control of acute gout attacks and long-term reduction of SUA. In addition, we aimed to provide new directions for the improvement of therapeutic measures and the development of drugs. Although Western medicine can significantly contribute to the treatment of gout, Chinese herbal medicine has unique advantages, including reduced adverse reactions and higher patient compliance. It may also fill in the shortcomings of Western medicine in the intermittent period treatment of gout. In addition to constantly exploring pathogenesis and drug targets, research on Chinese herbal medicine is equally important. The combination of Chinese and Western medicine has proven to become an important direction for gout treatment.

Keywords

gout therapy research progress Chinese medicine Western medicine 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Elfishawi MM, Zleik N, Kvrgic Z, Michet CJ, Crowson CS, Matteson EL, et al. The rising incidence of gout and the increasing burden of comorbidities: a population-based study over 20 years. J Rheumatol 2018;45:574–579.CrossRefGoogle Scholar
  2. 2.
    Robinson PC, Horsburgh S. Gout: joints and beyond, epidemiology, clinical features, treatment and comorbidities. Maturitas 2014;78:245–251.CrossRefGoogle Scholar
  3. 3.
    Edwards NL, So A. Emerging therapies for gout. Rheum Dis Clin North Am 2014;40:375–387.CrossRefGoogle Scholar
  4. 4.
    Broz P, Dixit VM. Inflammasomes: mechanism of assembly, regulation and signalling. Nat Rev Immunol 2016;16:407–420.CrossRefGoogle Scholar
  5. 5.
    Desai J, Kumar SV, Mulay SR, Konrad L, Romoli S, Schauer C, et al. PMA and crystal-induced neutrophil extracellular trap formation involves RIPK1-RIPK3-MLKL signaling. Eur J Immunol 2016;46:223–229.CrossRefGoogle Scholar
  6. 6.
    Chen YH, Hsieh SC, Chen WY, Li KJ, Wu CH, Wu PC, et al. Spontaneous resolution of acute gouty arthritis is aßsociated with rapid induction of the anti-inflammatory factors TGFβ1, IL-10 and soluble TNF receptors and the intracellular cytokine negative regulators CIS and SOCS3. Ann Rheum Dis 2011;70:1655–1663.CrossRefGoogle Scholar
  7. 7.
    Youm YH, Nguyen KY, Grant RW, Goldberg EL, Bodogai M, Kim D, et al. The ketone metabolite ß-hydroxybutyrate blocks NLRP3 inflammasome-mediated inflammatory disease. Nat Med 2015;21:263–269.CrossRefGoogle Scholar
  8. 8.
    Chinese Medical Association Rheumatology Branch. The Chinese Guideline for Gout Treatment 2016. Chin J Intern Med (Chin) 2016;11:892-899.Google Scholar
  9. 9.
    Steinberg AS, Vince BD, Choi YJ, Martin RL, Mcwherter CA, Boudes PF. The pharmacodynamics, pharmacokinetics, and safety of arhalofenate in combination with febuxostat when treating hyperuricemia associated with gout. J Rheumatol 2017;44:374–379.CrossRefGoogle Scholar
  10. 10.
    Zhong SY. Discussion on diagnosis and treatment of gout. Shandong J Tradit Chin Med (Chin) 2002;11:646–647.Google Scholar
  11. 11.
    The State Administration of Traditional Chinese Medicine. The Chinese medicine diagnosis and treatment program of 95 diseases in 22 specialties. Beijing: The State Administration of Traditional Chinese Medicine;2010:269-273.Google Scholar
  12. 12.
    Kong LD, Cai Y, Huang WW, Cheng CHK, Tan RX. Inhibition of xanthine oxidase by some Chinese medicinal plants used to treat gout. J Ethnopharm 2000;73:199–207.CrossRefGoogle Scholar
  13. 13.
    Zhou Q, Zhang N, Lu F, Liu SM. Effects of total saponins from Rhizoma Dioscoreae nipponicae on expreßsion of IL-1β and the signal pathway which is regulated in synovium of joint in rats of gouty arthritis. Pharm Clin Chin Mater Med (Chin) 2013;6:52–57.Google Scholar
  14. 14.
    Wang P, Ren D, Chen Y, Jiang M, Wang R, Wang YG. Effect of sodium alginate addition to resveratrol on acute gouty arthritis. Cell Physiol Biochem 2015;36:201–207.CrossRefGoogle Scholar
  15. 15.
    Chen H, Zheng S, Wang Y, Zhu H, Liu Q, Xue Y, et al. The effect of resveratrol on the recurrent attacks of gouty arthritis. Clin Rheumatol 2016;35:1189–1195.CrossRefGoogle Scholar
  16. 16.
    Wang Y, Wang L, Li E, Li Y, Wang Z, Sun X, et al. Chuanhu Anti-gout Mixture versus colchicine for acute gouty arthritis: a randomized, double-blind, double-dummy, non-inferiority trial. Int J Med Sci 2014;11:880–885.CrossRefGoogle Scholar
  17. 17.
    Sun WF, Zhu MM, Li J, Zhang XX, Liu YW, Wu XR, et al. Effects of Xie-Zhuo-Chu-Bi-Fang on miR-34a and URAT1 and their relationship in hyperuricemic mice. J Ethnopharmacol 2015;161:163–169.CrossRefGoogle Scholar
  18. 18.
    Xu TT, Cheng ZK, Yi L, Xu WK. Substances of Smilax glabra inhibit xanthine oxidase activity. J Chin Med Mater (Chin) 2012;4:582–585.Google Scholar
  19. 19.
    Chen GL, Zhu LR, Na S, Li L. Effect of total saponin of Dioscorea on chronic hyperuricemia and expression of URAT1 in rats. China J Chin Mater Med (Chin) 2013;14:2348–2353.Google Scholar
  20. 20.
    Zhang XX, Sun WF, Hou Y, Liu YW, He Y. Clinical observation on Compound Tufuling Granules treating 40 cases of hyperuricemia: a randomize-controlled study. J Tradit Chin Med (Chin) 2016;1:41–45.Google Scholar
  21. 21.
    Li XX, Han M, Wang YY, Liu JP. Chinese herbal medicine for gout: a systematic review of randomized clinical trials. Clin Rheum 2013;32:943–959.CrossRefGoogle Scholar
  22. 22.
    Wu XH, Wang CZ, Wang SQ, Mi C, He Y, Zhang J, et al. Anti-hyperuricemia effects of allopurinol are improved by Smilax riparia, a traditional Chinese herbal medicine. J Ethnopharmacol 2015;162:362–368.CrossRefGoogle Scholar
  23. 23.
    Yuan X, Fan YS, Xie GQ, Feng XH, Wu QM, Jin YM. Clinical study on 28 patients with acute gouty arthritis treated by Modified Simiao Pills combined with Western medicine. J Tradit Chin Med (Chin) 2017;24:2107–2110.Google Scholar
  24. 24.
    Zhang AH, Cai SP, Mao ZZ. Clinical observation of treating 65 cases with acute gout by integrating Western and traditional Chinese medicine. Chin J Bas Med Tradit Chin Med (Chin) 2001;5:41–42.Google Scholar
  25. 25.
    Wang Y, Li B, Zhang M, Xu W, Zhou R, Zhou M. Stagebased treatment of gouty arthritis by combination therapy of traditional Chinese and Western medicines: a randomized controlled trial. J Integr Med (Chin) 2008;6:576–580.CrossRefGoogle Scholar

Copyright information

© Chinese Association of the Integration of Traditional and Western Medicine 2019

Authors and Affiliations

  1. 1.Department of Endocrinology, The Affiliated Hospital of Medical CollegeQingdao UniversityQingdaoChina

Personalised recommendations